Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
When tirzepatide earned FDA approval for obesity under the brand name Zepbound, it marked the first dual-action GLP-1/GIP therapy officially recognized for chronic weight management
Our focus is not simply on providing a therapy but on helping patients make informed decisions that contribute to long-term health and wellness
Emerging research shows that people who develop sustainable habits while on the medication are more likely to prevent weight regain in the long term 11
Unfortunately, many people stop taking weight loss drugs because of the cost, or because their insurance companies wont cover them
US$ 22.66
US$ 28.27
US$ 26.28
US$ 20.42
US$ 23.85
US$ 27.65
US$ 27.23
US$ 23.19
US$ 22.60
US$ 24.91
